You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alpha 1-Antitrypsin Deficiency

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alpha 1-Antitrypsin Deficiency Trial in Charleston (KB408 (Nebulization))

Not yet recruiting
  • Alpha 1-Antitrypsin Deficiency
  • KB408 (Nebulization)
  • Charleston, South Carolina
    Medical University of South Carolina
Sep 20, 2023

Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection)

Not yet recruiting
  • Alpha1-Antitrypsin Deficiency
  • Fazirsiran Injection
  • (no location specified)
Jun 16, 2023

Alpha-1 Antitrypsin Deficiency Trial in San Diego, Boston, Saint Louis (Liver Biopsy (Biopsy Group Only))

Recruiting
  • Alpha-1 Antitrypsin Deficiency
  • Liver Biopsy (Biopsy Group Only)
  • San Diego, California
  • +2 more
Dec 13, 2022

Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)

Recruiting
  • Alpha-1 Antitrypsin Deficiency
  • Alpha-1 Antitrypsin Genotype
  • Gainesville, Florida
    University of Florida
Nov 2, 2022

Alpha 1-Antitrypsin Deficiency, Emphysema Trial (INBRX-101)

Not yet recruiting
  • Alpha 1-Antitrypsin Deficiency
  • Emphysema
  • (no location specified)
May 31, 2023

Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))

Recruiting
  • Alpha1-Antitrypsin Deficiency
  • Alpha-1 15%
  • Liquid Alpha1-Proteinase Inhibitor (Human)
  • Gainesville, Florida
  • +5 more
Jan 13, 2023

Alpha-1 Foundation DNA and Tissue Bank

Enrolling by invitation
  • Alpha 1 Antitrypsin Deficiency
    • Gainesville, Florida
      University of Florida
    Sep 19, 2022

    Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)

    Not yet recruiting
    • Alpha1-Antitrypsin Deficiency
    • Fazirsiran Injection
    • Placebo
    • (no location specified)
    Feb 2, 2023

    Alpha-1 Antitrypsin Deficiency Trial (VX-668, Placebo)

    Not yet recruiting
    • Alpha-1 Antitrypsin Deficiency
    • (no location specified)
    Feb 3, 2023

    Alpha 1-Antitrypsin Deficiency Trial in Grafton (Belcesiran)

    Withdrawn
    • Alpha 1-Antitrypsin Deficiency
    • Grafton, Auckland, New Zealand
      Auckland Clinical Studies
    Jun 22, 2022

    Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

    Completed
    Has Results
    • Alpha 1-Antitrypsin Deficiency
    • ADVM-043
    • Gainesville, Florida
    • +1 more
    Aug 3, 2022

    Alpha-1 Antitrypsin Deficiency Trial in Hannibal, Houston (VX-864)

    Recruiting
    • Alpha-1 Antitrypsin Deficiency
    • Hannibal, Missouri
    • +1 more
    Dec 22, 2022

    COPD, Lung Function Decreased, Alpha 1-Antitrypsin Trial in Kanifing

    Not yet recruiting
    • COPD
    • +2 more
      • Kanifing, Gambia
        Gamcotrap
      Aug 31, 2023

      Alpha 1-Antitrypsin Deficiency Trial in Tempe (VX-634, Placebo)

      Recruiting
      • Alpha 1-Antitrypsin Deficiency
      • Tempe, Arizona
        Celerion - Tempe
      Nov 9, 2022

      Intrauterine Growth Restriction in Pre-eclamptic Women

      Not yet recruiting
      • alpha1 Anti-trypsin
      • +2 more
      • Alpha1 -Antitrypsin level
      • (no location specified)
      Nov 18, 2022

      Alpha1-Antitrypsin Deficiency Trial in Aomori, Hokkaido, Tokyo (Alpha-1 MP)

      Completed
      Has Results
      • Alpha1-Antitrypsin Deficiency
      • Alpha-1 MP
      • Aomori, Japan
      • +2 more
      Mar 22, 2022

      Alpha 1-Antitrypsin Deficiency Trial in Austria, Germany, United Kingdom (ARO-AAT Injection)

      Active, not recruiting
      • Alpha 1-Antitrypsin Deficiency
      • ARO-AAT Injection
      • Vienna, Austria
      • +3 more
      Apr 28, 2022

      Alpha-1-antitrypsin Deficiency Trial in Praha

      Recruiting
      • Alpha-1-antitrypsin Deficiency
        • Praha, Czech Republic, Czechia
          Thomayer university hospital
        Dec 16, 2021

        COPD Exacerbation Blood and Urine Biomarkers Study

        Recruiting
        • Chronic Obstructive Pulmonary Disease
        • +2 more
          • New York, New York
            Columbia University Medical Center
          Oct 11, 2022

          Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency Trial in Worldwide (Alpha-1 MP)

          Enrolling by invitation
          • Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
          • Alpha-1 MP
          • Phoenix, Arizona
          • +24 more
          Dec 7, 2022

          Alpha 1-Antitrypsin Deficiency, Genetic Disease Trial in United States

          Recruiting
          • Alpha 1-Antitrypsin Deficiency
          • Genetic Disease
            • Birmingham, Alabama
            • +9 more
            Jul 4, 2022

            COPD (COPD), Alpha1-Antitrypsin Deficiency Trial (ARALAST NP, Another Available A1PI)

            Not yet recruiting
            • Chronic Obstructive Pulmonary Disease (COPD)
            • Alpha1-Antitrypsin Deficiency
            • ARALAST NP
            • Another Available A1PI
            • (no location specified)
            Jul 18, 2022

            Alpha1-Antitrypsin Deficiency Trial in Sapporo, Tokyo (Alpha-1 MP)

            Completed
            Has Results
            • Alpha1-Antitrypsin Deficiency
            • Alpha-1 MP
            • Sapporo, Japan
            • +1 more
            Oct 13, 2021

            Functional and Structural Lung Imaging in Chronic Obstructive

            Recruiting
            • Chronic Obstructive Pulmonary Disease
            • Alpha 1-Antitrypsin Deficiency
            • Lung MRI scan
            • Nottingham, Nottinghamshire, United Kingdom
              Sir Peter Mansfield Imaging Centre, University of Nottingham
            May 17, 2022

            Chronic Pancreatitis Trial in Charleston (Prolastin-C, Placebo)

            Active, not recruiting
            • Chronic Pancreatitis
            • Charleston, South Carolina
              Medical University of South Carolina
            Mar 23, 2022